| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |